Imperial College Academic Health Science Centre expansion

Imperial College Academic Health Science Centre has expanded enabling it to further accelerate health research and innovation, at scale, in West London.

In addition to the existing member organisations, Imperial College London, Imperial College Healthcare NHS Trust, The Royal Marsden NHS Foundation Trust, the Institute of Cancer Research and Chelsea & Westminster NHS Foundation Trust, the AHSC now also includes The Hillingdon Hospitals NHS Foundation Trust, London North West University Healthcare NHS Trust, and Brunel University of London.

Leaders from the eight member organisations came together last week, with the new AHSC Chair, Imperial President, Professor Hugh Brady, to set out a new and ambitious vision for the partnership.

Professor Hugh Brady said: “No single institution can solve the biggest challenges facing healthcare alone. By working together, we can deliver greater impacts for patients, communities and the health system as a whole”.

The AHSC’s expansion brings together the largest NHS provider collaborative in England, the NWL Acute Provider Group, the Royal Marsden NHS Foundation Trust and some of the world’s leading research organisations. By connecting academic and NHS organisations across 14 hospitals and ~2800 academic staff, the expanded partnership will further strengthen the partnership’s capability to translate excellent discovery science into better health outcomes at pace and scale.

This ecosystem serves a diverse and ethnically rich population of 2.7m people with access to world class research facilities, resources and talent enabling development and evaluation of health innovations. Based in West London, the AHSC partnership delivers impacts nationally and globally.

Professor Mark Thursz, AHSC Director, said: “Expansion will accelerate the real-world health impacts of our research and education mission and better address health inequalities, by strengthening our translational research ecosystem and extending our support for the workforce of the future. We can now harness biomedical and clinical capability from across the sector to deliver system-wide benefits in our focus areas of digital health and AI, early diagnosis and disease prevention.”